Moderna
E337017
Moderna is a biotechnology company best known for pioneering mRNA-based vaccines, including one of the first widely used COVID-19 vaccines.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Moderna canonical | 2 |
| ModernaTX, Inc. | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T3205348 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Moderna Context triple: [COVID-19 pandemic, majorVaccineDeveloper, Moderna]
-
A.
Pfizer–BioNTech
Pfizer–BioNTech is a pharmaceutical partnership best known for developing one of the first widely authorized mRNA vaccines against COVID-19.
-
B.
BioNTech
BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.
-
C.
Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
-
D.
Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
-
E.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Moderna Target entity description: Moderna is a biotechnology company best known for pioneering mRNA-based vaccines, including one of the first widely used COVID-19 vaccines.
-
A.
Pfizer–BioNTech
Pfizer–BioNTech is a pharmaceutical partnership best known for developing one of the first widely authorized mRNA vaccines against COVID-19.
-
B.
BioNTech
BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.
-
C.
Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
-
D.
Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
-
E.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
- F. None of above. chosen
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology company
ⓘ
public company ⓘ vaccine manufacturer ⓘ |
| collaboratedWith |
NIAID
ⓘ
National Institutes of Health ⓘ U.S. government Operation Warp Speed ⓘ |
| country |
United States
ⓘ
linked to:
United States of America
|
| developed |
Spikevax
ⓘ
mRNA-1273 ⓘ |
| focusesOn |
autoimmune disease therapeutics
ⓘ
cardiovascular disease therapeutics ⓘ infectious disease vaccines ⓘ mRNA technology ⓘ oncology therapeutics ⓘ rare disease therapeutics ⓘ therapeutic vaccines ⓘ |
| foundedBy |
Derrick Rossi
ⓘ
Flagship Pioneering ⓘ Kenneth Chien ⓘ Noubar Afeyan ⓘ Robert Langer ⓘ |
| hasAbbreviation |
MRNA
ⓘ
linked to:
mRNA vaccine
|
| hasChiefExecutiveOfficer | Stéphane Bancel ⓘ |
| hasResearchArea |
CMV vaccines
ⓘ
HIV vaccines ⓘ RSV vaccines ⓘ cancer vaccines ⓘ influenza vaccines ⓘ pandemic preparedness ⓘ personalized neoantigen vaccines ⓘ |
| hasSubsidiaryOrUnit |
ModernaTX, Inc.
ⓘ
linked to:
Moderna
|
| hasTechnologyPlatform |
lipid nanoparticle delivery
ⓘ
messenger RNA (mRNA) ⓘ |
| headquartersLocation | Cambridge, Massachusetts ⓘ |
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| knownFor |
mRNA-based COVID-19 vaccine
ⓘ
pioneering mRNA vaccines ⓘ |
| locatedIn |
Massachusetts
ⓘ
United States ⓘ
linked to:
United States of America
|
| productType | mRNA vaccine ⓘ |
| receivedAuthorizationFor |
COVID-19 vaccine
ⓘ
linked to:
COVID-19 vaccines
|
| receivedEmergencyUseAuthorizationIn |
Canada
ⓘ
European Union ⓘ United Kingdom ⓘ United States ⓘ
linked to:
United States of America
|
| tradedAs | NASDAQ:MRNA ⓘ |
| usesDeliverySystem | lipid nanoparticles ⓘ |
| vaccineType | mRNA COVID-19 vaccine ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Moderna Description of subject: Moderna is a biotechnology company best known for pioneering mRNA-based vaccines, including one of the first widely used COVID-19 vaccines.
Referenced by (3)
Full triples — surface form annotated when it differs from this entity's canonical label.
linked to: Moderna